— Seattle venture capital firm Madrona Venture Group announced it added three new venture partners: Loren Alhadeff, Mark Nelson, and Ted Kummert. Alhadeff, formerly the COO of DocuSign, has more… Read More
When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
— Flexible warehousing company Flexe hired Amazon vet Lara Rogers as SVP and general manager. Rogers spent the past decade at Amazon and was most recently director of business, product… Read More
Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer’s and Parkinson’s disease, the Seattle company announced… Read More
Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The company’s RNA editing technologies are spun out of the lab… Read More